Thoracic aortic aneurysm (TAA), without rupture, designated by code I71.2, is a clinical condition characterized by a permanent abnormal dilation of the aorta within the thoracic cavity, typically defined as an increase in diameter of at least 50% compared to the normal vessel segment. This code specifically encompasses aneurysms located in the ascending aorta, the aortic arch, or the descending thoracic aorta above the level of the diaphragm. It is distinct from thoracoabdominal aortic aneurysms (I71.6), which cross the diaphragm and involve both the thoracic and abdominal segments. Pathologically, TAAs often result from cystic medial necrosis, long-standing systemic hypertension, or atherosclerosis, and are highly associated with tobacco use and genetic syndromes such as Marfan syndrome, Loeys-Dietz syndrome, and Vascular Ehlers-Danlos syndrome. Most TAAs are clinically silent and detected incidentally on imaging; however, as they expand, they may compress adjacent structures or progress toward life-threatening dissection or rupture. Management is guided by aneurysm diameter, growth rate, and underlying etiology, with surgical or endovascular (TEVAR) intervention typically recommended once the diameter reaches 5.0–5.5 cm for the ascending aorta or 5.5–6.0 cm for the descending thoracic aorta.
Specify the exact segment of the thoracic aorta involved to ensure coding accuracy and clinical clarity.
Example: Patient with known 4.8 cm ascending thoracic aortic aneurysm, without rupture. Imaging confirms no involvement of the aortic arch or descending segment. Chronic condition remains stable on medical therapy. The specificity of the ascending segment supports the I71.2 diagnosis while guiding surgical planning and HCC risk adjustment for chronic cardiovascular management.
Billing Focus: Specific anatomical site (ascending vs. arch vs. descending).
Clearly document the maximum diameter of the aneurysm and the rate of growth since previous imaging.
Example: Follow-up for thoracic aortic aneurysm, without rupture. Current CTA chest shows the descending thoracic aorta measures 5.2 cm, increased from 4.9 cm six months ago (growth rate 0.6 cm/year). Blood pressure is managed with lisinopril to mitigate expansion risk. Documenting growth rates justifies the medical necessity for high-complexity decision making and increased monitoring frequency.
Billing Focus: Measurement accuracy and clinical progression documentation.
Differentiate between an isolated thoracic aneurysm and a thoracoabdominal aneurysm.
Example: Evaluation of aortic pathology shows a fusiform thoracic aortic aneurysm, without rupture, limited to the segment superior to the diaphragm. No extension into the abdominal aorta is noted. This distinction is critical as extension below the diaphragm would require the use of I71.6 (Thoracoabdominal aortic aneurysm) instead of I71.2.
Billing Focus: Correct ICD-10-CM code selection based on anatomical extension.
Document associated genetic syndromes or connective tissue disorders if present.
Example: Patient with Marfan syndrome and an associated 4.5 cm thoracic aortic aneurysm, without rupture. Aortic valve is currently competent. Managing BP with Losartan to reduce wall stress. Linking the aneurysm to the underlying genetic condition (Q87.40) provides a more complete clinical picture for risk-based reimbursement models.
Billing Focus: Reporting of secondary/underlying causative conditions.
Record the absence of rupture or dissection to confirm the appropriateness of I71.2.
Example: A 65-year-old male presents with incidental finding of a 4.2 cm thoracic aortic aneurysm, without rupture. Patient is currently asymptomatic with no evidence of acute dissection or leakage on CTA. This documentation supports the I71.2 code rather than the acute/emergent I71.0 or I71.1 codes.
Billing Focus: Exclusion of acute complications (rupture or dissection).
Moderate MDM is appropriate for managing a chronic condition with potential for progression and requiring diagnostic interpretation.
Standard of care for initial screening and serial monitoring of ascending thoracic aneurysms.
Necessary for precise measurement of all thoracic segments and pre-surgical mapping.
Definitive surgical treatment for large or rapidly growing ascending thoracic aneurysms.
Standard treatment for descending thoracic aneurysms that meet surgical criteria.
High MDM is justified when the risk of morbidity or mortality is high due to impending rupture or complex surgical needs.
Preferred in younger patients (e.g., Marfan) to minimize lifetime cumulative radiation dose during serial monitoring.
High MDM is required when evaluating a new, potentially life-threatening vascular condition for the first time.
Often used intraoperatively or when TTE images are suboptimal for assessing the aortic arch.
Necessary for complex anatomy not suitable for endovascular (TEVAR) approaches.